Clinical Trial Update: Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lymphoseek as a lymphoid tissue targeting agent in colon and rectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Rectal Cancer

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Colon Cancer, Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-05-20